Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on NOVO NORDISK A/S
02/23 NOVO NORDISK A/S : SHAREHOLDER ALERT - - Bronstein, Gewirtz & Grossman, LLC Remi..
02/23 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/23 NOVO NORDISK A/S : files annual report with the SEC
02/23 NOVO NORDISK A/S : - Share repurchase programme
02/23 NOVO NORDISK A/S : Imperial College London - Type 2 diabetes prevented in 80 per..
02/22 NOVO NORDISK A/S : Canadian News Media Challenged to See the Whole Picture When ..
02/20 NOVO NORDISK A/S : - Share repurchase programme
02/18 NOVO NORDISK SHAREHOLDER ALERT BY FO : Kahn Swick & Foti, LLC Reminds Investors ..
02/18 NOVO NORDISK A/S : Pomerantz Law Firm Reminds Shareholders with Losses on their ..
02/17 Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Act..
02/16 NOVO NORDISK A/S : Studies from Novo Nordisk in the Area of Obesity Reported (Ca..
02/16 NOVO NORDISK A/S : Researchers from Novo Nordisk Report Details of New Studies a..
02/16 NOVO NORDISK A/S : Findings in the Area of Proinsulin Reported from Novo Nordisk..
02/16 NOVO NORDISK A/S : Patent Issued for Method for Producing Acylated Peptides (USP..
02/16 NOVO NORDISK A/S : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Remind..
02/15 NOVO NORDISK A/S : Share repurchase programme
02/14 DEADLINE ALERT : Brower Piven Alerts Shareholders Of Approaching Deadline In Cla..
02/14 NVO INVESTORS ALERT : Lieff Cabraser Announces Securities Class Action Against N..
02/14 NOVO NORDISK A/S : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Remind..
02/14 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/14 NOVO NORDISK A/S : Trading in Novo Nordisk Shares by Board Members, Executives, ..
02/13 NVO The Law Offices of Vincent Wong Reminds Investors of a Class Action Invol..
02/13 NOVO NORDISK A/S : - Share repurchase programme
02/13 NOVO NORDISK A/S : Whitehouse Laboratories to Co-Present with Novo Nordisk at PD..
02/10 NOVO NORDISK A/S : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Remind..
02/09 NOVO NORDISK A/S : The Law Offices of Howard G. Smith Announces the Filing of a ..
02/09 ROBBINS ARROYO LLP : Novo Nordisk A/S NVO Misled Shareholders According to a Rec..
02/09 NOVO NORDISK A/S : files annual report with the SEC
02/08 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/07 NOVO NORDISK A/S : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class..
02/07 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/07 NOVO NORDISK A/S : publishes its 2016 Annual Report
02/06 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/06 NOVO NORDISK A/S : increased adjusted operating profit by 6% in local currencies..
02/02 NVO LOSS NOTICE : Rosen Law Firm Reminds Novo Nordisk A/S Investors of Important..
02/02 TRUMP EN VA-T-EN-GUERRE, INCERTITUDE : les bourses européennes ont terminé en or..
02/02 NOVO NORDISK A/S : Glancy Prongay & Murray LLP Commences Investigation on Behalf..
02/02 Law Offices of Howard G. Smith Commences Investigation on Behalf of Novo Nord..
02/02 European shares fall weighed down by poor earnings; Reckitt up
02/02 NOVO NORDISK A/S : misses 4Q profit forecasts
02/02DJNOVO NORDISK A/S : Shares Drop After Guidance Cut
02/02 NOVO NORDISK A/S : increased adjusted operating profit by 6% in local currencies..
02/01 NOVO NORDISK A/S : Glancy Prongay & Murray Announces the Filing of a Securities ..
02/01 NOVO NORDISK A/S : - Share repurchase programme
01/31 NOVO NORDISK A/S : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Clas..
01/31 NOVO NORDISK A/S : Chief Secretary welcomes an investment of more than 100 milli..
01/31 NOVO NORDISK A/S : World Protein Therapeutics Market by 2021-Analysis, Growth, D..
01/31 NOVO NORDISK A/S : Drug firm injects £115m in Oxford research centre
01/31 Drugmakers of insulin accused of price fixing
01/30 NOVO NORDISK A/S : Share repurchase programme
01/30 NOVO NORDISK A/S : Levi & Korsinsky, LLP Notifies Shareholders of Novo Nordisk A..
01/30 NOVO NORDISK A/S : University of Oxford - Novo Nordisk enters collaboration with..
01/30 NOVO NORDISK A/S : enters collaboration with University of Oxford on type 2 diab..
01/30 NOVO NORDISK A/S : Launch Collaborative Project with University of Oxford and In..
01/27 NOVO NORDISK A/S : The Law Offices of Howard G. Smith Announces the Filing of a ..
01/27 ROBBINS ARROYO LLP : Novo Nordisk A/S (NVO) Misled Shareholders According to a R..
01/26 NOVO NORDISK A/S : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifi..
01/25 NVO LOSS NOTICE : Rosen Law Firm Reminds Novo Nordisk A/S Investors of Important..
01/24 Law Offices of Howard G. Smith Commences Investigation on Behalf of Novo Nord..
01/23 NOVO NORDISK A/S : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifi..
01/23 NOVO NORDISK A/S : - Share repurchase programme
01/23 Agenda Out for Pharmaceutical Freeze Drying 2017 Summit Featuring Pfizer, Boe..
01/21 Agenda Released for Pharmaceutical Freeze Drying 2017 Summit Featuring Pfizer..
01/20 CLASS PERIOD EXPANDED IN CLASS ACTION LAWSUIT – Brower Piven Encourages..
01/20 NOVO NORDISK A/S : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Clas..
01/20 GLANCY PRONGAY & MURRAY LLP : Commences Investigation on Behalf of Novo Nordisk ..
01/16 LAWSUIT FOR INVESTORS WHO LOST MONEY : Nvo)
01/16 NOVO NORDISK A/S : - Share repurchase programme
01/13 Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against No..
01/12 NOVO NORDISK A/S : An Application for the Trademark "SOLVE" Has Been Filed by No..
01/12 NOVO NORDISK A/S : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Clas..
01/12 REPORTS ON GLUCAGON THERAPY FROM NOV : Chemical...
01/12 NOVO NORDISK A/S : Researchers Submit Patent Application, "Mating Factor Alpha P..
01/12 INVESTIGATORS AT NOVO NORDISK TARGET : ...
01/11 NOVO NORDISK A/S : Fiasp (fast-acting insulin aspart) approved in Europe
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ( DKK)
Sales 2017 116 577 M
EBIT 2017 50 067 M
Net income 2017 38 357 M
Finance 2017 14 922 M
Yield 2017 3,08%
P/E ratio 2017 16,06
P/E ratio 2018 14,55
EV / Sales 2017 4,18x
EV / Sales 2018 3,98x
Capitalization 501 933 M
More Financials
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 32
Average target price 273  DKK
Spread / Average Target 9,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Lars Fruergaard Jørgensen President & Chief Executive Officer
Göran Albert Ando Chairman
Jesper Brandgaard Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Mads Krogsgaard Chief Science Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S-3.02%71 279
JOHNSON & JOHNSON3.86%325 158
ROCHE HOLDING LTD.5.98%210 992
PFIZER INC.3.51%203 836
NOVARTIS AG3.51%202 566
MERCK & CO., INC.11.23%180 014
More Results